Categories: Approval

Aarti Industries Ltd’s Group Companies get Shareholders Approval for Amalgamation Scheme


Mumbai, 13 Mar, 2015: 
Aarti Industries Limited, a leading manufacturer and exporter of chemicals and pharmaceuticals, has received approval from shareholders of Anushakti Holdings Ltd (AHL) and Anushakti Chemical and Drugs Ltd (ACDL) for the scheme of amalgamation.

Shareholders of AHL & ACDL have approved the said Scheme unanimously by requisite majority at the court convened Meetings held on 9th March, 2015. All the Shareholders of Gogri & Sons Investments Private Limited (GSIPL) and Alchemie Leasing and Financing Private Limited (ALFPL) had given their consents/approval for the Scheme earlier.

Under the said Scheme, GSIPL, ALFPL, AHL and ACDL (Transferor Companies) would be amalgamated with Aarti Industries Limited.

Necessary Petitions are being filed for confirmation of the said Scheme of Amalgamation in the High Courts of Gujarat at Ahmedabad and of Bombay. The said Scheme is expected to be operational after obtaining requisite High Court orders and completion of process related thereto within next 4-5 months.

Upon the Scheme becoming effective, the paid up share capital of the Company, based on shareholding pattern as on 06/03/2015, is expected to be reduced by about 5.95% resulting in 83.32 million equity shares of Rs. 5/- each fully paid up. This would result in increased shareholder value in the long term.

The merger is aimed at simplification and rationalisation of the promoters’ shareholding and would also result in increase in public float of shares. Further, merger will also result in elimination of associate companies and would make the shareholding structure more transparent and investor friendly,” said Mr. Rajendra Gogri, Chairman and Managing Director, Aarti Industries Ltd.

Anushakti is an associate company of Aarti, with Aarti holding 49.6% equity stake in Anushakti. It is mainly engaged into manufacturing of various speciality chemicals with applications into end-user segments of performance chemicals, agrochemicals and pharmaceuticals.

The company has its manufacturing units at in Gujarat and Maharashtra & a pharma R&D centre in Maharashtra.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

23 hours ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago